FSK FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages FS KKR Capital Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 6 Deadline in Securities Class Action – FSK
NEW YORK, June 28, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FS KKR Capital Corp. (NYSE: FSK) between
PHREESIA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PHR
NEW YORK, June 28, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May
CHX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ChampionX Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CHX
NEW YORK, June 28, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February
POET DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages POET Technologies Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET
NEW YORK, June 28, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of POET Technologies Inc. (NASDAQ: POET) between April
UVAS and Go Dairy Sign MoU to Advance Agricultural Technologies in Pakistan
LAHORE: The University of Veterinary and Animal Sciences (UVAS) Lahore and Go Dairy Private Limited (GDPL) have formalized a partnership to enhance agricultural and animal husbandry technologies in Pakistan. The
PharmaVista 2026 Webinar Highlights Global Trends in Pharmaceutical Research
Lahore: The Department of Pharmacy successfully hosted the inaugural international Continuous Pharmacy Education webinar, PharmaVista 2026: Recent Trends in Pharmaceutical Research, drawing over 120 participants worldwide. The virtual event, held